Medical School of Chinese PLA, Beijing, China.
Department of Orthopedic Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
J Orthop Surg Res. 2020 Sep 4;15(1):382. doi: 10.1186/s13018-020-01923-z.
The proper timing of reimplantation is importation to treatment success in the two-stage exchange revision. The 2018 International Consensus Meeting suggested that a variation trend toward normalization in serum markers was useful for determining the proper timing of reimplantation. However, the opposite results were found by previous studies, and the normalization of serum markers was reported to fail to predict infection control. We investigated whether value changes and percent changes in four common serum markers (erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), interleukin-6 (IL-6), and fibrinogen) can predict persistent infection.
A retrospective review of 141 patients treated with the two-stage revision from 2014 to 2018 was conducted. The variation trend in serum indicators was evaluated by the percent changes (using values of serum markers pre-reimplantation divided by values pre-resection) and value changes (using values of serum markers pre-resection minus values pre-reimplantation). Treatment success was defined according to the Delphi-based consensus criteria with a minimum follow-up of 1 year, and the receiver operator characteristic (ROC) was used to examine the usefulness of changes in serum markers.
Twenty-two patients (15.60%) were persistently infected. No significant difference was found in either the value change or percent change in serum markers between reinfection and non-reinfection patients. When predicting persistent infection, the area under the curves (AUC) demonstrated that both percent changes and value changes in serum markers were poor indicators. The AUC of value changes was 0.533 for the CRP, 0.504 for the IL-6, 0.508 for the ESR, and 0.586 for fibrinogen when predicted persistent PJI. In addition, the AUC indicated that percent changes in the CRP (0.464), the IL-6 (0.534), the ESR (0.527), and fibrinogen (0.586) were all poor markers.
We have shown that both value changes and percent changes in serum markers were not sufficiently rigorous to aid in persistent infection diagnosis. The proper timing of reimplantation must, therefore, take into account various clinical tests rather than the downward trend of serum markers only.
在两阶段翻修的二期交换中,恰当的再植入时机对于治疗成功至关重要。2018 年国际共识会议建议,血清标志物的变化趋势向正常化对于确定恰当的再植入时机是有用的。然而,之前的研究结果却相反,并且有报道称血清标志物的正常化无法预测感染控制。我们研究了四种常见的血清标志物(红细胞沉降率(ESR)、C 反应蛋白(CRP)、白细胞介素-6(IL-6)和纤维蛋白原)的数值变化和百分比变化是否可以预测持续性感染。
回顾性分析了 2014 年至 2018 年期间接受两阶段翻修治疗的 141 例患者。通过百分比变化(使用再植入前的血清标志物值除以切除前的血清标志物值)和数值变化(使用切除前的血清标志物值减去再植入前的血清标志物值)来评估血清指标的变化趋势。根据基于 Delphi 的共识标准,将治疗成功定义为至少 1 年的随访期,并使用受试者工作特征(ROC)曲线来检查血清标志物变化的有用性。
22 例患者(15.60%)持续感染。再感染和非再感染患者的血清标志物数值变化或百分比变化无显著差异。在预测持续性感染时,ROC 曲线显示,血清标志物的数值变化和百分比变化都是较差的指标。CRP 的曲线下面积(AUC)为 0.533,IL-6 的 AUC 为 0.504,ESR 的 AUC 为 0.508,纤维蛋白原的 AUC 为 0.586,用于预测持续性 PJI。此外,AUC 表明 CRP(0.464)、IL-6(0.534)、ESR(0.527)和纤维蛋白原(0.586)的百分比变化都是较差的指标。
我们表明,血清标志物的数值变化和百分比变化都不足以帮助诊断持续性感染。因此,恰当的再植入时机必须考虑到各种临床检查,而不仅仅是血清标志物的下降趋势。